Intelligent Bio Solutions (NASDAQ:INBS) Shares Down 0.6% – Here’s Why

Intelligent Bio Solutions Inc. (NASDAQ:INBS)’s stock price dropped 0.6% on Wednesday . The company traded as low as $1.58 and last traded at $1.64. Approximately 53,755 shares traded hands during trading, a decline of 96% from the average daily volume of 1,367,589 shares. The stock had previously closed at $1.65.

Intelligent Bio Solutions Stock Performance

The business’s 50 day simple moving average is $1.55 and its two-hundred day simple moving average is $1.64.

Intelligent Bio Solutions (NASDAQ:INBS) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.70) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.17). The firm had revenue of $872.29 million for the quarter. Intelligent Bio Solutions had a negative net margin of 288.35% and a negative return on equity of 147.50%. On average, equities research analysts predict that Intelligent Bio Solutions Inc. will post -1.25 earnings per share for the current year.

About Intelligent Bio Solutions

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.